NCT06802627 Prehabilitation for Lung Cancer Patients Undergoing Lung Resection Status NOT_YET_RECRUITING Phase NA
NCT06790797 Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients Status RECRUITING Phase N/A
NCT06790355 ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population Status NOT_YET_RECRUITING Phase NA
NCT06789562 F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer Status NOT_YET_RECRUITING Phase N/A
NCT06789276 The Impact of Thoracic Paravertebral Nerve Block At Different Positions on Pain Relief in Patients Undergoing Single-Port Thoracoscopic Partial Lung Resection Status NOT_YET_RECRUITING Phase NA
NCT06778863 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation Status RECRUITING Phase PHASE1
NCT06776588 Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy Status RECRUITING Phase NA
NCT06771947 Predicting Symptom Trajectories After Thoracoscopic Lung Cancer Surgery Using an Interpretable Machine Learning Model Status NOT_YET_RECRUITING Phase N/A
NCT06756295 A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR) Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06751576 Retrospective Clinical Trial Comparing Radiologists' Diagnosis Accuracy in Lung Cancer Screening Population With and Without the Help of an AI/ML Tech-based SaMD Status COMPLETED Phase N/A
NCT06749886 An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting Status RECRUITING Phase PHASE2
NCT06749860 Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression Status RECRUITING Phase PHASE2
NCT06742021 Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer Status RECRUITING Phase NA
NCT06722885 Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System Status WITHDRAWN Phase N/A
NCT06716580 EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations Status RECRUITING Phase NA
NCT06698042 A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06692972 The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy Status RECRUITING Phase N/A